These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11084918)

  • 1. [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
    Kanazawa J; Morimoto M; Ohmori K
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):215-23. PubMed ID: 11084918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of vinorelbine in the cancer therapy.
    Galano G; Caputo M; Tecce MF; Capasso A
    Curr Drug Saf; 2011 Jul; 6(3):185-93. PubMed ID: 22122393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinorelbine: a novel vinca alkaloid.
    Toso C; Lindley C
    Am J Health Syst Pharm; 1995 Jun; 52(12):1287-304; quizz 1340-1. PubMed ID: 7656116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.
    Kruczynski A; Hill BT
    Crit Rev Oncol Hematol; 2001 Nov; 40(2):159-73. PubMed ID: 11682323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of vinorelbine in gastrointestinal cancers.
    Conroy T
    Crit Rev Oncol Hematol; 2002 May; 42(2):173-8. PubMed ID: 12007975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vinorelbine in the treatment of non-small-cell lung cancer and breast cancer].
    Kubota K
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1301-6. PubMed ID: 10945030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC). The Japan Vinorelbine Lung Cancer Cooperative Study Group.
    Furuse K; Fukuoka M; Kuba M; Yamori S; Nakai Y; Negoro S; Katagami N; Takada Y; Kinuwaki E; Kawahara M; Kubota K; Sakuma A; Niitani H
    Ann Oncol; 1996 Oct; 7(8):815-20. PubMed ID: 8922195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinorelbine (Navelbine): a third-generation vinca alkaloid.
    Budman DR
    Cancer Invest; 1997; 15(5):475-90. PubMed ID: 9316630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Navelbine (vinorelbine): a review of its antitumor activity and toxicity in clinical studies].
    Niitani H
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1495-507. PubMed ID: 10500542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.
    Goa KL; Faulds D
    Drugs Aging; 1994 Sep; 5(3):200-34. PubMed ID: 7803948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A trial with single-agent vinorelbine in taxane-resistant non-small cell lung cancer].
    Miyata J; Sano T; Bando H
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):239-42. PubMed ID: 11242654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor activity of navelbine (vinorelbine ditartrate), a new vinca alkaloid analog].
    Ashizawa T; Miyoshi K; Asada M; Kobayashi E; Okabe M; Morimoto M; Gomi K; Hirata T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):59-66. PubMed ID: 8422187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy with vinorelbine and other cytotoxic agents for advanced breast cancer patients--a protocol of vinorelbine plus AC regimens used by the Japan Vinorelbin Study Group].
    Saeki T; Adachi I; Ogita M; Tabei T; Shin E; Tamura K; Takashima S
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1180-4. PubMed ID: 10945014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase‑inhibitory fluoropyrimidine in EGFR‑mutated lung adenocarcinoma: retrospective and in vitro studies.
    Izumi H; Touge H; Igishi T; Makino H; Nishii-Ito S; Takata M; Nakazaki H; Ueda Y; Matsumoto S; Kodani M; Kurai J; Takeda K; Sakamoto T; Yanai M; Tanaka N; Nirodi CS; Shimizu E
    Int J Oncol; 2015 Mar; 46(3):989-98. PubMed ID: 25573239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
    Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
    Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells.
    Chiu WH; Luo SJ; Chen CL; Cheng JH; Hsieh CY; Wang CY; Huang WC; Su WC; Lin CF
    Biochem Pharmacol; 2012 May; 83(9):1159-71. PubMed ID: 22285910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-agent vinorelbine in the treatment of non-small cell lung cancer.
    Wozniak AJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):62-6; discussion 71-2. PubMed ID: 10585010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells.
    Chiu WH; Su WC; Li CL; Chen CL; Lin CF
    Oncotarget; 2015 Aug; 6(24):20513-24. PubMed ID: 26001295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: a new highly active chemotherapeutic regimen.
    Gebbia V; Testa A; Borsellino N; Ferrera P; Tirrito M; Palmeri S
    Ann Oncol; 2001 Jun; 12(6):767-72. PubMed ID: 11484950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.